We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about Medicare's coverage for annual lung cancer screenings, including eligibility criteria, costs, benefits, and risks. Find out if you qualify for a low-dose CT scan.

Lung cancer remains a significant health concern, particularly for older adults. Fortunately, advancements in medical technology and expanded healthcare coverage mean that early detection is more accessible than ever. Medicare, the federal health insurance program for individuals aged 65 and older, plays a crucial role in this by covering annual lung cancer screenings for eligible beneficiaries. This blog post will delve into the latest Medicare guidelines for lung cancer screening, helping you understand if you qualify and what to expect. Understanding Lung Cancer and Screening Lung cancer is a leading cause of cancer-related deaths globally. The National Cancer Institute (NCI) reports that it is the third most commonly diagnosed cancer in the United States and often appears after the age of 65. Early detection is paramount, as the 5-year relative survival rate significantly improves when the cancer is caught in its initial stages. Screening tests, such as the low-dose computed tomography (LDCT) scan, are designed to find lung cancer in people who have a high risk but no symptoms. Medicare Coverage for Lung Cancer Screenings Medicare Part B, which covers outpatient services and diagnostic tests, provides coverage for one annual lung cancer screening using a low-dose CT scan. This coverage is a vital part of ensuring that those at high risk have access to potentially life-saving early detection. Who Qualifies for Medicare Lung Cancer Screening? The Centers for Medicare and Medicaid Services (CMS) updated its coverage criteria in 2022 to align more closely with the U.S. Preventive Services Task Force (USPSTF) guidelines. To be eligible for Medicare-covered lung cancer screening, you must meet the following criteria: Age: You must be between 50 and 77 years old. Smoking History: You must currently smoke or have quit smoking within the last 15 years. Pack-Year History: You must have a history of smoking at least 20 pack-years. A pack-year is defined as smoking an average of 20 cigarettes (one pack) per day for one year. No Symptoms: You must not have any signs or symptoms of lung cancer. If you have symptoms, a different diagnostic pathway will be followed. Physician's Order: You need a written request or order for the low-dose CT scan from your doctor or another qualified healthcare professional who accepts Medicare. These updated guidelines are a significant improvement, as they lower the previous pack-year requirement, making screening accessible to a broader group of individuals at high risk. What is a Low-Dose CT Scan? A low-dose computed tomography (LDCT) scan is a special X-ray test that takes detailed pictures of your lungs. It uses a lower dose of radiation than a standard CT scan, making it safer for regular screening purposes. The scan is quick and painless, typically taking only a few minutes. It is performed while you lie on a table that slides into a donut-shaped machine. Cost of Lung Cancer Screening Under Medicare Lung cancer screenings are considered a preventive service under Medicare Part B. This means that if you meet the eligibility criteria and have a doctor's order, Medicare generally covers 100% of the cost of the screening, provided you have met your Part B deductible. If you have not yet met your annual Part B deductible (which is $240 for 2024), you may be responsible for paying up to that amount. It's important to note that if your screening reveals any abnormalities, further diagnostic tests or treatments may incur additional costs. However, Medicare also provides coverage for lung cancer treatment, with similar cost-sharing rules applying after the deductible is met. Where Can You Get Screened? To ensure the quality and accuracy of the screening, Medicare covers LDCT scans performed at facilities that meet specific standards. These facilities must: Use low-dose CT scanners. Adhere to established protocols for examining and interpreting lung nodules, as determined by the American College of Radiology (ACR). You can find a list of qualifying screening sites by visiting the ACR website or by asking your doctor for a referral to an accredited facility. Benefits and Risks of Lung Cancer Screening The primary benefit of lung cancer screening is the potential for early detection. When lung cancer is found early, treatment is often more effective, leading to higher survival rates. For instance, data from the NCI shows a notable decrease in lung cancer mortality rates in recent years, partly due to improved screening and treatment methods. However, like any medical procedure, lung cancer screening carries some risks: Radiation Exposure: LDCT scans involve a small amount of radiation. While the dose is low, repeated exposure over time is a consideration. False Positives: The screening might detect abnormalities that turn out not to be cancer, leading to unnecessary anxiety and further invasive tests. False Negatives: It's possible for the screening to miss a small or early-stage cancer. Overdiagnosis: Sometimes, slow-growing cancers are detected that might never have caused harm or symptoms during a person's lifetime. Despite these risks, for individuals who meet the high-risk criteria, the benefits of early detection through annual screening generally outweigh the potential harms. When to Consult a Doctor If you fall within the age and smoking history criteria for Medicare lung cancer screening, it is highly recommended to discuss this with your doctor. They can assess your individual risk factors, explain the benefits and risks in detail, and provide the necessary order for a screening if appropriate. Furthermore, if you experience any new or persistent symptoms that could be related to
In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026